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We have investigated the intracellular traffic of PrPc,
a glycosylphosphatidylinositol (GPI)-anchored protein
implicated in spongiform encephalopathies. A fluorescent functional green fluorescent protein (GFP)-tagged
version of PrPc is found at the cell surface and in intracellular compartments in SN56 cells. Confocal microscopy and organelle-specific markers suggest that the
protein is found in both the Golgi and the recycling
endosomal compartment. Perturbation of endocytosis
with a dynamin I-K44A dominant-negative mutant altered the steady-state distribution of the GFP-PrPc,
leading to the accumulation of fluorescence in unfissioned endocytic intermediates. These pre-endocytic intermediates did not seem to accumulate GFP-GPI, a
minimum GPI-anchored protein, suggesting that PrPc
trafficking does not depend solely on the GPI anchor.
We found that internalized GFP-PrPc accumulates in
Rab5-positive endosomes and that a Rab5 mutant alters
the steady-state distribution of GFP-PrPc but not that of
GFP-GPI between the plasma membrane and early endosomes. Therefore, we conclude that PrPc internalizes
via a dynamin-dependent endocytic pathway and that
the protein is targeted to the recycling endosomal compartment via Rab5-positive early endosomes. These observations indicate that traffic of GFP-PrPc is not determined predominantly by the GPI anchor and that,
different from other GPI-anchored proteins, PrPc is delivered to classic endosomes after internalization.
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The cellular prion protein (PrPc)1 is a glycosylphosphatidylinositol (GPI)-plasma membrane-anchored protein whose
function is still under debate. Potential roles of PrPc in signaling events (1–5), cell adhesion and differentiation (6, 7), protection against oxidative insults (8 –10), and copper metabolism
(8, 11) have been suggested. Conversion of PrPc from an ␣-helix- to a ␤-sheet-rich structure causes relevant biophysical
changes to the protein that have been related to brain dysfunction in prion diseases (12–14). The mechanisms involved in this
conversion are unknown, but accumulating evidence suggests
that the process occurs after PrPc reaches the plasma membrane, and it may involve PrPc entry into intracellular acidic
organelles (15–17).
The mechanisms of PrPc trafficking are poorly understood. A
chicken PrPc has been shown to cycle through the plasma
membrane and endosomes (18), and this process has been
suggested to involve clathrin-mediated endocytosis (19). However, other evidence suggests that mammalian PrPc may follow
a similar endocytic pathway as that of most GPI-anchored
proteins. In particular, PrPc can be found in lipid rafts at the
plasma membrane that are isolated as detergent-insoluble glycolipid vesicles (17, 20 –22). Moreover, it has been suggested
that internalization of PrPc occurs via a clathrin-independent
mechanism, probably through “caveolae” (20, 21).
Internalization of GPI-anchored proteins is a complicated
cellular event, because these proteins lack intracellular oriented sequences that are relevant for interaction with endocytic adaptor proteins. A minimum fluorescent GPI-anchored
protein, GFP (green fluorescent protein)-GPI continuously cycles through the plasma membrane and the Golgi compartment
without passing through classic endocytic organelles in a clathrin-independent fashion, suggesting that there is a default
trafficking pathway that is followed by some GPI-anchored
proteins (23). However, other GPI-anchored proteins such as
the folate receptor pass through recycling endosomes before
returning to the plasma membrane (23–25). Lipid rafts are
heterologous structures and not all GPI-anchored proteins
are clustered in the same rafts in cells (22). Thus, it is possible
that multiple endocytic pathways contribute to the internalization of different GPI proteins.
Recently, we (26) and others (27–29) have generated distinct
fluorescent PrPc molecules (GFP-PrPc). The fluorescent protein

1
The abbreviations used are: PrPc, cellular prion protein; GPI, glycosylphosphatidylinositol; GFP, green fluorescent protein; MEM, minimal essential medium; DIC, differential interference contrast; Tfn,
transferrin.
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FIG. 1. Colocalization of GFP-PrPc with Golgi and endosomal markers. SN56 cells were transiently transfected with the GFP-PrPc
construct and 48 h after transfection, living cells were labeled with the specified marker and examined by laser scanning confocal microscopy. A–C,
individual optical sections of the same cell transfected with GFP-PrPc (green, upper panel) and labeled with Ceramide-Bodipy TR (red, middle
panel) and the respective superimposed images (lower panel). The distance of the Z axis between each image is shown. The cell is representative
of 59 cells examined in different experiments. D–F, individual optical sections of a cell transfected with GFP-PrPc (green, upper panel) and labeled
with Transferrin-alexa 568 (red, middle panel) and the respective superimposed images (lower panel). The distance of the Z axis between each
image is shown. The cell is representative of 23 cells examined in different experiments. G, an optical section of SN56 cells transfected with
GFP-PrPc; H, an optical section of SN56 cells labeled with FM4-64. I, overlay of G and H. J, respective differential interference contrast (DIC)
image. The cells are representative of 37 cells examined. Scale bars, 20 m.

is correctly targeted to the plasma membrane, where it is
anchored by GPI (26, 28) and is present in rafts (28). Importantly, copper induces GFP-PrPc internalization (26) in a similar way to its effect on PrPc (11, 30), suggesting that the
fluorescent protein is functional and can be used to infer PrPc
traffic in living cells.
In the present work we examined the intracellular localization of GFP-PrPc and disrupted distinct steps of the endocytic
pathway to uncover intermediates involved in PrPc trafficking.
Moreover, we tested whether the same endocytic intermediates
required for PrPc trafficking also participate in the trafficking
of a minimum GPI-anchored protein, GFP-GPI. We found that
the steady-state distribution of GFP-PrPc is dynamin-regulated and that internalized GFP-PrPc is localized to Rab5positive early endocytic vesicles and endosomes. In contrast,
GFP-GPI is not found in the same endocytic organelles as
GFP-PrPc. Consequently, we suggest that PrPc trafficking differs from that of other standard GPI-anchored proteins and
may depend on additional internalization signals present in
the protein.
EXPERIMENTAL PROCEDURES

Cell Culture—The SN56 cells were a generous gift from Prof. Bruce
Wainer (Department of Pathology, Emory University School of Medi-

cine, Atlanta, GA). Cells were maintained in Dulbecco’s modified Eagle’s medium (Sigma Chemical Co., St. Louis, MO), 10% fetal bovine
serum (Invitrogen), 2 mM L-glutamine, and 1% penicillin/streptomycin
in 25-cm2 culture bottles in a 5% CO2 atmosphere at 37 °C as described
previously (26, 32). The SN56 cells were derived from septum neurons
(31) and present a number of neuronal features, including expression of
synaptic vesicle proteins (32) and neuronal type calcium channels (33).
Such features are increased by differentiation (33, 34).
Plasmids—The GFP-PrPc vector has been described previously (26).
The constitutively activated Rab5 mutant Q79L (Q79L), dynamin I
(dynamin), and the dominant-negative dynamin I mutant K44A (K44A)
plasmids were a gift from Prof. Marc G. Caron (Department of Cell
Biology, Duke University and Howard Hughes Medical Institute). GFPGPI was a gift from Benjamin J. Nichols and J. Lippincott-Schwartz
(Medical Research Council Laboratory of Molecular Biology, United
Kingdom, and Cell Biology and Metabolism Branch, NICHD, National
Institutes of Health).
Cell Transfection—The SN56 cells were plated on coverslips 1 day
before transfection. Cell transfection was performed by the liposomemediated method (LipofectAMINE 2000, Invitrogen, Gaithersburg,
MD) according to the manufacturer’s instructions. One microgram of
plasmid and 2.5 l of LipofectAMINE 2000 were used for 5.5 ⫻ 104 cells.
After 4 h of transfection, cells were maintained in serum-free medium
and differentiated for 2 days. In co-transfection experiments we used
3– 4 g of DNA (with a proportional change of LipofectAMINE 2000),
following a plasmid ratio of 1:3 (Rab5-Q79L) or 1:2 (dynamin I or
dynamin I-K44A) for GFP-PrPc and the other plasmids.
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FIG. 2. Dynamin is involved in PrPc endocytosis. SN56 cells were co-transfected with construct GFP-PrPc and Dynamin or the mutant
K44A. Forty-eight hours after transfection, living cells were labeled with FM4-64 and examined by laser scanning confocal microscopy. A, digital
reconstruction (maximum Z projection) of a cell co-transfected with GFP-PrPc and Dynamin. Note that FM4-64 can be internalized by this cell (B).
C, shows superimposed images and (D) the respective DIC image. E, maximum Z projection of a cell co-transfected with GFP-PrPc and the mutant
K44A. Note the fluorescent structures close to the plasmalemma. F, internalization of FM4-64 for the same cell. Dynamin I-K44A-transfected cells
internalized much less FM4-64 than Dynamin-transfected cells. G, overlay of images E and F. H, respective DIC image. I–L, individual optical
sections of a cell co-transfected with GFP-PrPc and Dynamin I-K44A (green, upper panel) and labeled with FM4-64 (red, middle panel) and the
respective superimposed images (lower panel). The distance at the Z axis between each image is shown. Scale bar, 20 m.
Fluorescence Imaging—Live cell experiments were performed at
room temperature (20 –25 °C). Cells on coverslips were washed in MEM
(minimal essential medium, without phenol red) and transferred to a
custom holder in which the coverslip formed the bottom of a 400-l
bath. Imaging was performed with a Bio-Rad MRC 1024 laser scanning
confocal system running the software Lasersharp 3.0 coupled to a Zeiss
microscope (Axiovert 100) with a water immersion objective (40⫻, 1.2
numerical aperture) as described previously (26). Image analysis and
processing were performed with Lasersharp (Bio-Rad), Confocal Assistant, Adobe Photoshop, and Metamorph (Universal Imaging) software.
PrPc Internalization Assay—This assay has been previously described and shown to be dependent on the presence of the intact oct-

arepeat Cu2⫹ binding region of PrPc (26). Cells were perfused with
MEM and, after obtaining the first Z series (0 min), MEM with or
without 250 –500 M Cu2⫹ was perfused and another Z series was
acquired (15 min).
Labeling of Organelles—To label endocytic organelles, we used the
styryl dye FM4-64 (Molecular Probes, Eugene, OR). Cells were incubated with 16 M FM4-64 for 15– 40 min at 37 °C in 5% CO2 and then
visualized by confocal microscopy as previously described (35). Labeling
of endosomes was performed by incubating cells with 40 g/ml Alexa
Fluor 568-labeled transferrin (Tfn-568, Molecular Probes) at 37 °C in
5% CO2 for 20 min. After incubation, cells were washed three times
with ice-cold phosphate-buffered saline and then either imaged or fixed
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FIG. 3. Dynamin I does not interfere with the distribution of GFP-GPI. SN56 cells were co-transfected with the construct GFP-GPI and
Dynamin (A–D) or the dynamin I mutant K44A (E–H). Forty-eight hours after transfection, living cells were labeled with FM4-64 and examined
by laser scanning confocal microscopy. A, digital reconstruction of a cell co-transfected with GFP-GPI and Dynamin. B, internalization of FM4-64
by the same cell. C, shows the superimposed image and (D) the respective DIC image. E, digital reconstruction of a cell co-transfected with
GFP-GPI and K44A. F, internalization of FM4-64 by the same cell, note that less dye is internalized and there is no perinuclear accumulation. G,
shows the superimposed image and (H) the respective DIC image. Scale bar, 20 m.
with 3% paraformaldehyde in phosphate-buffered saline for 20 min for
posterior imaging. Golgi complex was identified with Ceramide-Bodipy
TR (Molecular Probes) as follows: cells were washed in HEPES-buffered
salt solution (in millimolar: 137 NaCl, 4 KCl, 2 CaCl2, 1.2 MgSO4,
10 glucose, 10 HEPES, pH 7.4, adjusted with NaOH) and preincubated
for 15 min at 37 °C and then 15 min at 4 °C with 5 M Bodipy TR
complexed with bovine serum albumin. Cells were then washed with
HEPES-buffered salt solution and incubated for further 30 min at 37 °C
before imaging. Two types of Ceramide-Bodipy (FL and TR) labeled the
same structures in SN56 cells, and labeling was completely abolished
by Brefeldin A. Moreover, Ceramide-Bodipy FL, which fluoresces in
green, co-localized with a red fluorescent variant of PrPc (not shown).
RESULTS

Co-localization of GFP-PrPc with Golgi and Endocytic Markers—Previous experiments using different GFP-PrPc constructions have suggested that the fluorescent protein labels the
Golgi compartment, as assessed by the co-localization of the
GFP-tagged protein with a number of Golgi markers (27–29).
Optical sections of living cells double-labeled with GFP-PrPc
and Ceramide-Bodipy TR confirmed these previous observations showing an excellent degree of localization of GFP-PrPc in
the Golgi apparatus in SN56 cells (Fig. 1, A–C). However, a
significant proportion of GFP-PrPc was localized to vesicular
structures that were labeled by the endosomal compartment
marker Tfn-568 (Fig. 1, D–F). A large proportion of the doublelabeled endosomes were packed within the perinuclear region,
although rare puncta in close proximity to the plasma membrane were also observed (Fig. 1D, arrow). Experiments with
the vital dye FM4-64 showed that the GFP-PrPc-labeled perinuclear structure can be partially labeled with this endocytic
tracer (Fig. 1, G–J). These observations suggest that intracellular GFP-PrPc is accumulating not only in the Golgi but also in
endosomal compartments.
Constitutive Traffic of GFP-PrPc but Not of GFP-GPI Is Perturbed by Dynamin I K44A—To determine the initial steps
involved with PrPc trafficking, we examined whether the expression of a dynamin I-K44A mutant might perturb GFP-PrPc
and GFP-GPI (a marker of non-clathrin-mediated endocytosis
(23)) distribution in SN56 cells. Expression of the dynamin
I-K44A dominant-negative mutant has been used extensively

as a tool to block fission of endocytic intermediates (36). When
dynamin I-K44A was co-expressed with GFP-PrPc in SN56
cells, GFP-PrPc was localized in structures close to the plasma
membrane surface (Fig. 2, E–G). In contrast, in cells co-expressing wild-type dynamin I, labeling of these structures was
not observed (Fig. 2, A–D). The internalization of FM4-64 (an
endocytic tracer dye) was also decreased in dynamin I-K44Aexpressing cells (Fig. 2, compare B with F), suggesting that
most of the FM4-64 accumulation in the perinuclear region
depends on dynamin activity. As expected, expression of dynamin I-K44A also inhibited by 75% the internalization of
fluorescent transferrin by these cells, suggesting that this mutant potently inhibits clathrin-mediated endocytosis (37).
Fig. 2 (I–L) shows in more detail the GFP-PrPc structures
that appear in dynamin I-K44A co-transfected cells. Few vesicles labeled with GFP-PrPc close to the plasma membrane
could also be labeled with FM4-64 (Fig. 2, I–L). The labeling
varied from cell to cell, but some cells showed large numbers of
GFP-positive structures that were also stained with FM4-64
(see Fig. 2J). Optical sectioning of regions close to the top of the
cell shows that these structures most often appeared to be
connected to the plasmalemma and perhaps to the exterior
milieu, because they are accessible to the impermeant dye
FM4-64 (Fig. 2, I and J). Sections toward the middle of the cell
show the presence of fluorescent GFP puncta in close association with the plasma membrane (Fig. 2, K and L). The structures labeled with GFP-PrPc in dynamin I-K44A-expressing
cells were similar to those described for some plasma membrane receptors that continuously traffic between the plasmalemma and the cytoplasm (38). In some cells (Fig. 2E), the
expression of the GFP-PrPc was limited to intense vesicular
patches with very little diffuse labeling of the plasma membrane, suggesting that the GFP-PrPc is constitutively endocytosed. In contrast, under conditions where expression of the
dominant-negative dynamin I-K44A mutant blocked uptake of
FM4-64 into SN56 cells, there is little change in the subcellular
localization of GFP-GPI (compare Fig. 3, A and E). Thus, GFPGPI exhibits a similar pattern of distribution in wild-type and
mutant dynamin-expressing cells (Fig. 3). These observations
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FIG. 4. GFP-PrPc co-localizes with endocytic vesicles away from the perinuclear region in Rab5-Q79L-expressing cells. SN56 cells
were transfected with GFP-PrPc and the Rab5-Q79L mutant, or with GFP-GPI and Rab5-Q79L. Forty-eight hours after transfection, living cells
were labeled with FM4-64 for 20 min and were examined by laser scanning confocal microscopy. Individual optical sections of a representative
co-transfected cell expressing GFP-PrPc and Rab5-Q79L (green) and labeled with FM4-64 (red) are shown in A and B. The Z axis distance between
each image is shown at the bottom, and Z projection for this cell is presented in C. Note the presence of GFP-PrPc vesicles away from the perinuclear
region, which are uncommon in the absence of Rab5-Q79L construct (see Fig. 1). Arrows point to vesicles where co-localization is found. The result
is representative for 90 cells examined with 70 cells presenting GFP-PrPc structures labeled with FM4-64. D and E, individual optical sections of
a co-transfected cell expressing GFP-GPI and Rab5-Q79L (green) and labeled with FM4-64 (red). The Z axis distance between each image is shown
at the bottom, and the Z projection of the same cell is presented in F. The result is representative of 34 cells in which only one showed co-localization
of FM4-64 and GFP-GPI. Scale bar, 20 m.

indicate that the structures labeled with GFP-PrPc do not
participate in the internalization of GFP-GPI.
GFP-PrPc but Not GFP-GPI Is Trafficked to Rab5-positive Endosomes—The observation that GFP-PrPc, but not GFP-GPI,
accumulated in vesicles connected to the plasma membrane in
the presence of dynamin I-K44A prompted us to investigate the
cellular organelles underlying the constitutive trafficking of
PrPc. We detected some events of co-localization between GFPPrPc and Tfn-568 in puncta close to the plasma membrane in
cells (Fig. 1), with a more extensive co-localization observed in
the perinuclear region. Therefore, we examined whether GFPPrPc either transits or bypasses the Rab5-positive early endosomal compartment to reach the perinuclear compartment of cells.
Rab5 is involved in endosomal traffic and fusion. A Rab5-Q79L
mutant that mimics the GTP-bound form of Rab5 and exhibits
constitutive activity promotes homotypic fusion of endocytic vesicles into enlarged vesicular structures (39, 40). If GFP-PrPc
bypasses this compartment, there should be no change in the
subcellular distribution of the GFP-tagged protein in the presence of Rab5-Q79L.
Images of cells overexpressing Rab5-Q79L show that GFPPrPc was readily identified in vesicles close to the plasma
membrane (Fig. 4, A–C, green). Some of the GFP-PrPcpositive vesicles were also labeled with the vital dye FM4-64
(Fig. 4, A–C, superimposed images labeled with arrows), and
in many cases we detected co-localization of GFP-PrPc with

the endocytic marker Tfn-568 (Fig. 5, A and B). These results
suggest the early endocytic origin of the GFP-PrPc-labeled
vesicles. In agreement with a previous report (23), GFP-GPI
did not localize in vesicles filled with FM4-64 or Tfn-568 in
the presence of Rab5-Q79L (Figs. 4, D–F, and 5, C and D).
Our experiments suggest that constitutive traffic of GFPPrPc is distinct from that of GFP-GPI for its sensitivity to K44A
and presence in Rab5-positive endosomes. However, these
studies did not determine whether GFP-PrPc enters early endosomes directly following internalization from the plasma
membrane or whether the fluorescent protein is indirectly redistributed to earlier endosomes. It is known that copper binds
to PrPc through an octarepeat region of amino acids (8, 41), and
among other changes Cu2⫹ induces PrPc internalization (11,
26, 30). We thus used Cu2⫹ to evoke synchronized GFP-PrPc
internalization in cells overexpressing Rab5-Q79L to determine whether these vesicles receive internalized GFP-PrPc.
Fig. 6 (A and B) shows that GFP-PrPc responded to copper and
accumulated in endocytic organelles in cells overexpressing
Rab5-Q79L (arrows). In the absence of Rab5 Q79L there was
only limited accumulation of GFP-PrPc in early endocytic vesicles (26). However, short term exposure to Cu2⫹ in the absence
of Rab5-Q79L induced the rapid accumulation of GFP-PrPc in
the perinuclear compartment (Fig. 6, G and H) (26). Taken
together, these observations suggest that under normal conditions GFP-PrPc transits very rapidly through the early endo-
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FIG. 5. GFP-PrPc co-localizes with Tfn-568 in Rab5 Q79L-expressing cells. SN56 cells were transfected with GFP-PrPc and the Rab5 Q79L
mutant, or with GFP-GPI and Rab5-Q79L. Forty-eight hours after transfection, cells were labeled with Tfn-568 for 20 min, fixed with paraformaldehyde 3%, and examined by laser scanning confocal microscopy. Two optical sections of representative cells expressing GFP-PrPc and
Rab5-Q79L are shown in A and B, whereas two optical sections of a representative cell expressing GFP-GPI and Rab5-Q79L are shown in C and
D. GFP-PrPc and GFP-GPI are presented in green, Tfn-568 is in red, and co-localization is seen in yellow in the superimposed images (lower panel).
Arrows point to vesicles presenting co-localization of GFP-PrPc and Tfn-568. The Z axis distance between each image is shown at the bottom. The
results are representative of 35 and 28 cells, respectively, for GFP-PrPc and GFP-GPI imaged in three independent experiments. Scale bar, 20 m.

somal compartment and that only following the perturbation of
endosomal trafficking is GFP-PrPc detected in early endosomes. This may be the consequence of the detection limits for
GFP-PrPc, and its localization may require increased accumulation of protein in early endosomes following Rab5-Q79L
expression. As expected, GFP-GPI, which is not found in
Tfn-positive endosomes (23), did not become internalized
through exposure of cells to Cu2⫹ (Fig. 6, D and E).
DISCUSSION

The present experiments using GFP-PrPc shed new light on
the mechanisms underlying the internalization and trafficking
of PrPc. We show that GFP-PrPc internalization is distinct from
the non-clathrin-mediated endocytosis defined for GFP-GPI
(23, 42), suggesting that PrPc-specific internalization signals
exist and override the default pathway conferred by the GPI
anchor. We also demonstrate that PrPc internalization is dependent upon dynamin I, a key mechano-enzyme involved with
the fission of some, but not all (43, 44), endocytic vesicles from
the plasma membrane. Moreover, we also identify Rab5-positive early endosomes as the initial destination of internalized
GFP-PrPc in living cells.
Localization of PrPc in intracellular compartments has been
reported in neurons (45– 47), with strong expression in the
Golgi (47). More recently, expression of GFP-PrPc by several
research groups has also revealed the presence of the protein in
the Golgi compartment (27–29). We have confirmed these data
using a Golgi marker for living cells, however, by using endocytic markers and a Rab5 mutant we also found that part of the
intracellular GFP-PrPc can be found in the endosomal
compartment.
Discordant results have been reported regarding the mechanisms involved in the internalization of chicken and mammalian PrPc. Although chicken PrPc was reported to internalize
via clathrin-dependent endocytic vesicles (18), mammalian
PrPc was reported to depend on a caveolae-like mechanism of
endocytosis (17, 19, 21). The localization of mammalian PrPc to
classic endosomes is under debate (48), because many proteins
found in lipid rafts are thought to bypass this compartment (23,

42, 49). In contrast, GPI-anchored proteins such as the folate
receptor were found in Tfn-positive endosomes (24, 25). In the
present study, we found that GFP-PrPc transited rapidly
through the early endosomal compartment and that detection
of GFP-PrPc in early endosomes was only observed when
the compartment was perturbed by the overexpression of
Rab5-Q79L. These results agree with recent ultrastructural
localization of mammalian PrPc in neurons that has shown
labeling of the Golgi but also of cytoplasmic vesicular
organelles that might represent endosomes (47).
Internalization through caveolae seems to divert proteins
from the endosomal-lysosomal system (49). Moreover, caveolae
are immobile whenever cells are not stimulated, indicating that
they may not participate in constitutive traffic events (50).
Indeed, recent experiments suggest that non-clathrin-mediated endocytosis uses organelles distinct from classic endosomes (51). Internalization of GFP-GPI occurs independently of
clathrin; the protein bypasses the early endosomal system and
is not found in Rab5-Q79L generated endosomes (23, 51). If
internalized GFP-PrPc was also capable of bypassing classic
endosomes similar to GFP-GPI, it is unlikely that we would
have found the fluorescent protein in Tfn-positive Rab5-Q79Lgenerated endosomes.
The presence of PrPc in caveolar-like organelles has been
extensively reported (17, 20, 21), and an interaction between
PrPc and caveolin has been suggested (3). The present data
suggest that, if a non-clathrin mechanism of internalization of
PrPc, such as caveolae, is involved in the dynamin-dependent
internalization of PrPc, it represents some sort of specialization
that allows PrPc to enter the early endocytic pathway. An
alternative view is that clathrin-coated vesicles are involved
with mammalian PrPc trafficking similar to what has been
described for chicken PrPc (19). In agreement with the later
view, mammalian PrPc in neurons is found in coated pits (22,
47). These results agree with the observations that both intracellular injection of anti-caveolin or anti-clathrin antibodies
inhibited activation of the Fin kinase (that presumably occurs
intracellularly) induced by PrPc cross-linking with specific
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FIG. 6. Cu2ⴙ-induced internalization of GFP-PrPc to Rab5-Q79L vesicles. SN56 cells were transiently transfected with the GFP-PrPc,
GFP-PrPc, and Rab5 Q79L mutant or GFP-GPI and Rab5-Q79L. Forty-eight hours after transfection, cells were assayed for PrPc internalization
through perfusion with MEM plus Cu2⫹ (500 M) for 15 min. Z series were acquired before and after the perfusion. The maximum Z projection of
a co-transfected cell (representative of 31 independent experiments in which only three failed to detect internalization) expressing GFP-PrPc and
Rab5-Q79L is shown in A (t ⫽ 0 min) and B (t ⫽ 15 min). Images were pseudocolored to facilitate the distinction of differences in fluorescence.
Arrows point to vesicles showing an increase in fluorescence after Cu2⫹ perfusion, and arrowheads point to membrane regions with pronounced
loss of fluorescence. D (0 min) and E (15 min) show a Z projection of a co-transfected cell expressing GFP-GPI and Rab5-Q79L before and after
perfusion with Cu2⫹ (representative of 12 independent experiments). No significant differences were observed in GFP-GPI distribution after Cu2⫹
perfusion. G (0 min) and H (15 min) show an example of a cell expressing only GFP-PrPc before and after exposure to Cu2⫹. Respective DIC images
are presented in the right panels. Scale bar, 20 m.

antibodies (3). Together these results indicate that the initial
recruitment of PrPc to pre-endocytic membranes is a complex
event and may occur through more than one mechanism.
PrPc is a Cu2⫹ binding protein (8), but the consequences of
Cu2⫹ interaction with the protein for its physiological function
are poorly understood. It has been suggested that PrPc is used
to deliver Cu2⫹ to intracellular compartments (11) or that the
protein takes part in a mechanism of protection from oxidative
insults (8 –10). Coordinated decrease of fluorescence from the
plasma membrane with the simultaneous increase of GFP-PrPc
presence in the perinuclear compartment in response to Cu2⫹
has been previously reported (26). However, very few small
vesicles filled with GFP-PrPc can be distinguished close to the
plasma membrane after Cu2⫹ exposure in control cells. In
Rab5-Q79L-expressing cells, we could observe endosomes filled
with GFP-PrPc in response to Cu2⫹ (Fig. 6). This result suggests that at least part of both constitutive and Cu2⫹-evoked
GFP-PrPc endocytosis and intracellular trafficking is mediated
by early endosomes. Nonetheless, after internalization GFPPrPc seems to preferentially accumulate in a perinuclear compartment in SN56 cells.
It has been shown that some GPI-anchored proteins are
retained in the recycling endosomal compartment in a choles-

terol and “raft”-dependent fashion, suggesting that lipid “rafts”
may have important roles in sorting GPI-anchored proteins
from endosomes (25, 52). It is perhaps physiologically relevant
that PrPc stays longer and accumulates at the perinuclear
endosomal compartment, because the latter has lower pH than
the early endosomal compartment (53). PrPc binding to Cu2⫹ is
pH-sensitive (54, 55) and the presence of PrPc in more acidic
endosomes and its tendency to accumulate therein may allow
for correct conditions for PrPc to release Cu2⫹ inside the cell.
Alternatively, internalization of PrPc to endosomes may
have the role of switching off potential signaling through PrPc
(4, 5, 48).
PrPc has been shown to cycle constitutively through the
plasma membrane and intracellular compartments (18). The
mechanisms underlying PrPc internalization have remained
obscure, in particular, the role of dynamin in the fission of
vesicles bearing PrPc has not been previously tested. This is an
important question, because many plasma membrane proteins
are internalized by a dynamin-independent pathway (42– 44).
In fact, it is suggested that GPI-anchored proteins internalize
via a dynamin-independent mechanism (56, 57). Our data obtained in cells overexpressing the dynamin I-K44A dominantnegative show that GFP-PrPc trafficking and steady-state
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localization is dependent upon dynamin activity. We found that
a number of endocytic intermediates are generated in the presence of dynamin I-K44A that are with GFP-PrPc. These endocytic intermediates are localized in close proximity to the
plasma membrane and can be labeled with the membrane
impermeant dye FM4-64, suggesting that the lumen of these
intermediates are in contact with the extracellular medium.
These results are in sharp contrast with those obtained with
GFP-GPI, whose localization seems undisturbed in the presence of dynamin I-K44A.
There are reports of proteins that interact with PrPc with the
potential to regulate internalization (4, 58, 59). Whether these
or other proteins may participate in selection of PrPc for internalization or are responsible for diverting the fluorescent protein to the early endosomal pathway in dynamin I-generated
vesicles is at present unknown.
In conclusion, our data confirm that GPI-anchored proteins
may follow distinct pathways in cells and show that constitutive trafficking of PrPc differs in at least two fundamental
aspects from the trafficking of GFP-GPI. First, we observed
that the intracellular trafficking of cell surface PrPc involves a
dynamin-sensitive step. Second, we show that at least part of
the internalized PrPc transits through the Rab5-regulated
early endosomal compartment prior to the accumulation of
PrPc in the perinuclear compartment of cells. We propose that
the dynamin-dependent endocytosis of PrPc is GPI anchorindependent and may be mediated by the interaction of proteins with other domains of PrPc.
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